1.
Exploratory study of risk factors related to SARS-CoV-2 prevalence in nursing homes in Flanders (Belgium) during the first wave of the COVID-19 pandemic
2.
3.
4.
5.
6.
7.
8.
9.
Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in Flanders (Belgium) in fall 2020
Vaccine hesitancy towards the COVID-19 vaccine in a random national sample of Belgian nursing home staff members
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign
Vaccine Hesitancy towards the COVID-19 Vaccine in a Random National Sample of Belgian Nursing Home Staff Members
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 1 : februari 2021
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium in August 2021 : brief communication on preliminary results of the SCOPE study
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 2 : april 2021
Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium, SCOPE